Literature DB >> 283283

Some prognostic and epidemiologic factors in canine osteosarcoma.

W Misdorp, A A Hart.   

Abstract

Naturally occurring skeletal osteosarcomas in a series of 144 untreated dogs were found especially to involve the ends of the long bones of the forelimbs and affected predominantly older male dogs of giant and large breeds. Most tumors were large and partially necrotic and had extended into soft tissues. Of 12 host and tumor characteristics tested in the first part of the study, tumor diameter and volume were significantly associated with the presence of pulmonary metastases at autopsy. The second part of the study revealed that extension of the tumor into the soft tissues and localization of the tumor in the hind legs were associated with a poor prognosis, whereas the fibrosarcomatous type of tumor was associated, as in man, with a favorable prognosis. An association between the 12 characteristics tested was found in 11 of 78 combinations at the 5% level and in 5 combinations at the 1% level. Affected giant dogs were generally younger than affected small and medium-sized dogs. Especially in giant dogs, the osteosarcomas involved the long bones and were of relatively large diameters. The sarcomas in female dogs were larger in volume than those in males. Pure osteoblastic osteosarcomas were generally smaller than combined (chondroblastic and fibroblastic) osteosarcomas. Peritumorous lymphocytes and plasma cells were present in 50% of the dogs, especially in small and young dogs. When compared with a reference population, great Danes, rottweilers, German shepherds, and boxers were found to be overrepresented in the osteosarcoma group.

Entities:  

Mesh:

Year:  1979        PMID: 283283     DOI: 10.1093/jnci/62.3.537

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  22 in total

1.  Osteosarcoma of the talus in a dog.

Authors:  H R Sukhiani; M J Gains
Journal:  Can Vet J       Date:  1993-10       Impact factor: 1.008

2.  Anaplastic sarcoma of the mandible in a llama.

Authors:  E Malone; K Roertgen; C Kobluk
Journal:  Can Vet J       Date:  1996-07       Impact factor: 1.008

3.  Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.

Authors:  K A Skorupski; J M Uhl; A Szivek; S D Allstadt Frazier; R B Rebhun; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-10-04       Impact factor: 2.613

4.  Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway.

Authors:  Kristin P Anfinsen; Tom Grotmol; Oyvind S Bruland; Thora J Jonasdottir
Journal:  Can J Vet Res       Date:  2011-07       Impact factor: 1.310

5.  An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis.

Authors:  Hue H Luu; Quan Kang; Jong Kyung Park; Weike Si; Qing Luo; Wei Jiang; Hong Yin; Anthony G Montag; Michael A Simon; Terrance D Peabody; Rex C Haydon; Carrie W Rinker-Schaeffer; Tong-Chuan He
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 6.  Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment.

Authors:  E G MacEwen
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

7.  Bone tumors in a population of 400 000 insured Swedish dogs up to 10 y of age: incidence and survival.

Authors:  Agneta Egenvall; Ane Nødtvedt; Henrik von Euler
Journal:  Can J Vet Res       Date:  2007-10       Impact factor: 1.310

Review 8.  Canine sarcomas as a surrogate for the human disease.

Authors:  Daniel L Gustafson; Dawn L Duval; Daniel P Regan; Douglas H Thamm
Journal:  Pharmacol Ther       Date:  2018-03-09       Impact factor: 12.310

9.  Skeletal osteosarcoma. Animal model: canine osteosarcoma.

Authors:  W Misdorp
Journal:  Am J Pathol       Date:  1980-01       Impact factor: 4.307

10.  Establishment and characterization of a new highly metastatic human osteosarcoma cell line.

Authors:  Yuxi Su; Xiaoji Luo; Bai-Cheng He; Yi Wang; Liang Chen; Guo-Wei Zuo; Bo Liu; Yang Bi; Jiayi Huang; Gao-Hui Zhu; Yun He; Quan Kang; Jinyong Luo; Jikun Shen; Jin Chen; Xianqing Jin; Rex C Haydon; Tong-Chuan He; Hue H Luu
Journal:  Clin Exp Metastasis       Date:  2009-04-11       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.